000			01919 a2200613 4500
005			20250518073906.0
264		0	_c20201106
008			202011s 0 0 eng d
022			_a2045-2322
024	7		_a10.1038/s41598-019-55455-6 _2doi
040			_aNLM _beng _cNLM
100	1		_aMaoz, Myriam
245	0	0	_aClinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes. _h[electronic resource]
260			_bScientific reports _c12 2019
300			_a18795 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aCell Line, Tumor
650	0	4	_aDisease Progression
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aFemale
650	0	4	_aGene Amplification
650	0	4	_aGenes, erbB-2
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasms _xclassification
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aProtein Phosphatase 2C _xantagonists & inhibitors
650	0	4	_aReceptor, ErbB-2 _xgenetics
650	0	4	_aWhole Genome Sequencing
650	0	4	_aYoung Adult
700	1		_aDevir, Michal
700	1		_aInbar, Michal
700	1		_aInbar-Daniel, Ziva
700	1		_aSherill-Rofe, Dana
700	1		_aBloch, Idit
700	1		_aMeir, Karen
700	1		_aEdelman, David
700	1		_aAzzam, Salah
700	1		_aNechushtan, Hovav
700	1		_aMaimon, Ofra
700	1		_aUziely, Beatrice
700	1		_aKadouri, Luna
700	1		_aSonnenblick, Amir
700	1		_aEden, Amir
700	1		_aPeretz, Tamar
700	1		_aZick, Aviad
773	0		_tScientific reports _gvol. 9 _gno. 1 _gp. 18795
856	4	0	_uhttps://doi.org/10.1038/s41598-019-55455-6 _zAvailable from publisher's website
999			_c30410891 _d30410891